Viewing Study NCT03850769


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:33 PM
Study NCT ID: NCT03850769
Status: UNKNOWN
Last Update Posted: 2020-03-10
First Post: 2019-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module